CHITOSAN LOW MOLECULAR WEIGHT (20-200 MPA.S)

Summary

Chitosan Low Molecular Weight (20-200 Mpa.S) (CHEMBL4594468) is a phase-3 clinical-stage unknown.

At a glance

• Status: Max clinical phase 3 (not approved)
• Modality: Unknown
• Clinical trials: 2

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL4594468
Name	CHITOSAN LOW MOLECULAR WEIGHT (20-200 MPA.S)
Type	Unknown
Max phase	3

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indications (0 at ChEMBL trial phase 4).

Clinical trials

Total trials: 2.

Phase distribution

Phase	Trials
PHASE3	1
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04365270	PHASE3	COMPLETED	Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer
NCT07048028	Not specified	RECRUITING	Chitosan Irrigation in Premolar Root Canal Therapy (Randomized Trial)

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).